IL113076A - Pharmaceutical hypocholesterolemic and hypotriglyceridemic compositions containing tricyclic dipeptide derivatives of alpha-(aminoalkanoylthio) benzenepropionic acid - Google Patents

Pharmaceutical hypocholesterolemic and hypotriglyceridemic compositions containing tricyclic dipeptide derivatives of alpha-(aminoalkanoylthio) benzenepropionic acid

Info

Publication number
IL113076A
IL113076A IL11307695A IL11307695A IL113076A IL 113076 A IL113076 A IL 113076A IL 11307695 A IL11307695 A IL 11307695A IL 11307695 A IL11307695 A IL 11307695A IL 113076 A IL113076 A IL 113076A
Authority
IL
Israel
Prior art keywords
aminoalkanoylthio
hypotriglyceridemic
hypocholesterolemic
alpha
pharmaceutical
Prior art date
Application number
IL11307695A
Other languages
English (en)
Other versions
IL113076A0 (en
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of IL113076A0 publication Critical patent/IL113076A0/xx
Publication of IL113076A publication Critical patent/IL113076A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IL11307695A 1994-03-24 1995-03-22 Pharmaceutical hypocholesterolemic and hypotriglyceridemic compositions containing tricyclic dipeptide derivatives of alpha-(aminoalkanoylthio) benzenepropionic acid IL113076A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21735094A 1994-03-24 1994-03-24

Publications (2)

Publication Number Publication Date
IL113076A0 IL113076A0 (en) 1995-06-29
IL113076A true IL113076A (en) 2000-09-28

Family

ID=22810704

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11307695A IL113076A (en) 1994-03-24 1995-03-22 Pharmaceutical hypocholesterolemic and hypotriglyceridemic compositions containing tricyclic dipeptide derivatives of alpha-(aminoalkanoylthio) benzenepropionic acid

Country Status (19)

Country Link
US (2) US5624921A (de)
EP (1) EP0751783B1 (de)
JP (1) JPH09510476A (de)
CN (1) CN1144487A (de)
AT (1) ATE189392T1 (de)
AU (1) AU698320B2 (de)
CA (1) CA2184696C (de)
DE (1) DE69514912T2 (de)
DK (1) DK0751783T3 (de)
ES (1) ES2141923T3 (de)
FI (1) FI963783L (de)
GR (1) GR3033117T3 (de)
HU (1) HUT75160A (de)
IL (1) IL113076A (de)
NO (1) NO963987L (de)
NZ (1) NZ282568A (de)
PT (1) PT751783E (de)
WO (1) WO1995025532A1 (de)
ZA (1) ZA952284B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10229180A1 (de) * 2002-06-28 2004-01-29 Aventis Pharma Deutschland Gmbh Verwendung von Vasopeptidase-Inhibitoren bei der Behandlung von metabolischen Erkrankungen, Nephropathie und mit AGE assoziierten Erkrankungen
DE602004023100D1 (de) * 2003-10-08 2009-10-22 Lilly Co Eli Verbindungen und verfahren zur behandlung von dyslipidemie

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3334095A (en) * 1965-02-16 1967-08-01 Sandoz Ag Novel pyrrolo-oxazines and pyrrolo-oxazoles
US3334091A (en) * 1965-03-25 1967-08-01 Sandoz Ag Sedatives
GB1525845A (en) * 1976-07-30 1978-09-20 Ucb Sa 1,2,4,5-tetrahydro-3h-2-benzazepin-3-ones
IE50839B1 (en) * 1980-02-26 1986-07-23 Wyeth John & Brother Ltd Novel processes for preparing proline derivatives and analogous compounds
EP0042100A1 (de) * 1980-06-13 1981-12-23 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Pyrazolopyridazin-Derivate, Zwischenprodukte und Verfahren zu deren Herstellung, sowie diese enthaltende Arzneimittel
US4320057A (en) * 1980-06-23 1982-03-16 American Home Products Corporation Aryl--pyrrolo--thiazepin--diones and aryl--piperidino--thiazepin--diones
US4415496A (en) * 1981-03-23 1983-11-15 Merck & Co., Inc. Bicyclic lactams
GB2128984B (en) * 1982-05-12 1985-05-22 Hoffmann La Roche Diaza-bicyclic compounds
NZ204130A (en) * 1982-05-12 1986-03-14 Hoffmann La Roche Bicyclic heterocyclic compounds and pharmaceutical compositions
US4552889A (en) * 1983-06-09 1985-11-12 Eli Lilly And Company 3-Mercaptomethyl-2-oxo-1-pyrrolidine acetic acids and use for hypertension
US4692438A (en) * 1984-08-24 1987-09-08 Hoffmann-La Roche Inc. Pyridazo-diazepines, diazocines, and -triazepines having anti-hypertensive activity
US4584294A (en) * 1984-11-07 1986-04-22 Merck & Co., Inc. Fused tricyclic lactams as angiotensin converting enzyme inhibitors and as antihypertensive agents
ATE60605T1 (de) * 1985-04-30 1991-02-15 Lilly Co Eli 7-substituierte bicyclische pyrazolidinone.
ZA874106B (en) * 1986-06-13 1987-12-08 Merrell Dow Pharmaceuticals Inc. Novel antihypertensive agent
US4973585A (en) * 1986-06-13 1990-11-27 Merrell Dow Pharmaceuticals Tricyclic lactams active as antihypertensive agents
ZA874107B (de) * 1986-06-13 1987-12-09
GB8629875D0 (en) * 1986-12-15 1987-01-28 Hoffmann La Roche Pyridazodiazepine derivatives
US4824832A (en) * 1987-12-30 1989-04-25 Merrell Dow Pharmaceuticals Inc. Sulfhydryl containing tricyclic lactams and their pharmacological methods of use
US5061694A (en) * 1989-10-23 1991-10-29 E. R. Squibb & Sons, Inc. Method for stabilizing or causing regression of atherosclerosis in coronary arteries employing an ace inhibitor
GB8926512D0 (en) * 1989-11-23 1990-01-10 Pfizer Ltd Therapeutic agents
WO1991009840A1 (en) * 1989-12-22 1991-07-11 Schering Corporation Mercaptocycloacyl aminoacid endopeptidase inhibitors
FR2659332B1 (fr) * 1990-03-08 1994-04-29 Adit Et Cie Nouvelles pyrrolo [1,2-a] thieno [3,2-f] diazepines [1,4], leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
CA2053340C (en) * 1990-10-18 2002-04-02 Timothy P. Burkholder Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
EP0492369B1 (de) * 1990-12-21 1997-09-17 Merrell Pharmaceuticals Inc. Neue trizyklische Amino- und Nitro Verbindungen mit ACE-hemmenden Eigenschaften
US5208230A (en) * 1990-12-21 1993-05-04 Merrell Dow Pharmaceuticals Amino and nitro containing tricyclic compounds useful as inhibitors of ACE
FR2679564A1 (fr) * 1991-07-23 1993-01-29 Inst Nat Sante Rech Med Nouveaux acylmercaptoalcanoldipeptides, leur preparation et les compositions qui les contiennent.
CA2119019A1 (en) * 1991-09-16 1993-04-01 Harry R. Davis Pharmaceutical compositions comprising natriuretic peptides or neutral endopeptidase inhibitors for treating or preventing myointimal proliferation
AU668707B2 (en) * 1992-02-14 1996-05-16 Merrell Pharmaceuticals Inc. Aminoacetylmercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ACE
DK0640086T3 (da) * 1992-05-15 1999-12-06 Merrell Pharma Inc Mercaptoacetylamido-pyridazo[1,2-a][1,2]diazepin-derivateranvendelige som enkephalinase- og ACE-inhibitorer
RU2124503C1 (ru) * 1992-05-18 1999-01-10 И.Р.Сквибб энд Санз, Инк. Гетероциклические азотсодержащие производные карбоновой кислоты, способ их получения и фармацевтическая композиция
US5238932A (en) * 1992-05-20 1993-08-24 Merrell Dow Pharmaceuticals Inc. Mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase

Also Published As

Publication number Publication date
CA2184696A1 (en) 1995-09-28
EP0751783B1 (de) 2000-02-02
GR3033117T3 (en) 2000-08-31
US5602122A (en) 1997-02-11
NO963987D0 (no) 1996-09-23
FI963783A0 (fi) 1996-09-23
WO1995025532A1 (en) 1995-09-28
US5624921A (en) 1997-04-29
DK0751783T3 (da) 2000-06-26
FI963783A7 (fi) 1996-09-23
HUT75160A (en) 1997-04-28
CA2184696C (en) 2001-01-02
DE69514912D1 (de) 2000-03-09
ZA952284B (en) 1996-01-09
DE69514912T2 (de) 2000-10-05
IL113076A0 (en) 1995-06-29
CN1144487A (zh) 1997-03-05
AU1972495A (en) 1995-10-09
NZ282568A (en) 1997-07-27
PT751783E (pt) 2000-05-31
EP0751783A1 (de) 1997-01-08
ATE189392T1 (de) 2000-02-15
AU698320B2 (en) 1998-10-29
NO963987L (no) 1996-11-22
JPH09510476A (ja) 1997-10-21
ES2141923T3 (es) 2000-04-01
FI963783L (fi) 1996-09-23

Similar Documents

Publication Publication Date Title
BG103793A (en) COMBINED THERAPY USING BENZOTHIAPINS INHIBITING THE ILEAL BILE ACID TRANSPORT AND HMG Co-A REDUCTASE INHIBITORS
AU2490297A (en) Use of strontium salts for the production of pharmaceutical compositions intended for the treatment of arthrosis
IL126038A0 (en) Novel benzothiepines and derivatives thereof and pharmaceutical compositions comprising them
PL323825A1 (en) Peptidyloheterocycli compounds useful in treating diorders associated with thrombosin
GEP20043149B (en) Use of Substituted Azetidinones Agents
AU3435497A (en) Autocross-linked hyaluronic acid and related pharmaceutical compositions for the treatment of arthropathies
HUP9904221A3 (en) Use of cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia for producing pharmaceutical compositions
AU1729397A (en) Process to prepare soluble delivery systems using volatile salts
HUP9901359A3 (en) Azetidinone derivatives for the treatment of atherosclerosis, process for their producing and pharmaceutical compositions containing them
AU1912197A (en) New inhibitors of metalloprotease, process for preparing them and pharmaceutical compositions containing them
AU2740797A (en) Androstene derivatives
AUPO727097A0 (en) Method of treatment of hepatoma and pharmaceutical compositions for use therein
FR2754820B1 (fr) Le (-)hydroxycitrate de magnesium, procede de preparation, applications, et compositions notamment pharmaceutiques le renfermant
HUP9901153A3 (en) Azetidinone derivatives for the treatment of atherosclerosis, their production and pharmaceutical compositions containing them
PL340561A1 (en) Application of a combination of a converting enzyme inhibitor and a diuretic in treating microcirculatory disorders
AU4133997A (en) Pharmaceutical composition for the treatment of syndrome x of reaven
MX9403088A (es) Composiciones farmaceuticas que contienen deriva- dos de indol y metodos de uso.
UA35566C2 (uk) Лікарський засіб для профілактики і лікування порушень ліпоїдного і холестеринового обміну речовин і спосіб профілактики і лікування цих порушень
IL113076A (en) Pharmaceutical hypocholesterolemic and hypotriglyceridemic compositions containing tricyclic dipeptide derivatives of alpha-(aminoalkanoylthio) benzenepropionic acid
IL113074A (en) Hypocholesterolemic antiatherosclerotic and hypotriglyceridemic pharmaceutical compositions comprising derivatives of mercaptoacetamido-oxopyrrolo (and pyrido) benzazepinecarboxylic acids
SG81198A1 (en) Purified form of streptogramins, its preparation and pharmaceutical compositions containing it
AU5963396A (en) Cis-resorcylide, pharmaceutical composition containing it, use thereof in the treatment of thrombosis and related disorders
IL111804A0 (en) Pharmaceutical compositions comprising dimeticone for the treatment of constipation
GB2275269B (en) Purified form of streptogramins,its preparation and pharmaceutical compositions containing it
UA32580C2 (uk) Засіб для лікування паралітичної непрохідності кишечнику

Legal Events

Date Code Title Description
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees
HC Change of name of proprietor(s)

Owner name: AVENTIS INC.

Free format text: FORMER NAME:MERRELL PHARMACEUTICALS INC.